Novocure Ltd (NVCR) vs Sarepta Therapeutics, Inc. (SRPT)
A side-by-side comparison of Novocure Ltd and Sarepta Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NVCR
Novocure Ltd
$14.97HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SRPT
Sarepta Therapeutics, Inc.
$17.31HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — NVCR vs SRPT
growth of $100 · dividends reinvested · last 10yNVCR +73.5% (+5.7%/yr)SRPT -71.5% (-11.8%/yr)NVCR compounded faster over this window
Log scale — wide-divergence pair
NVCR SRPT
NVCR vs SRPT: by the numbers
- •SRPT is the larger company ($1.83B vs $1.74B market cap).
- •Both run net losses; SRPT's is the smaller (-6.93% vs -21.25% net margin).
- •SRPT grew revenue faster over the past five years (26.90% vs 5.12% CAGR).
Metrics side by side
Valuation
| Metric | NVCR | SRPT |
|---|---|---|
| Forward P/E | N/A | 5.38 |
| P/S ratio | 2.49 | 0.93 |
| P/B ratio | 5.16 | 1.20 |
Profitability
| Metric | NVCR | SRPT |
|---|---|---|
| Gross margin | 76.13% | 58.56% |
| Operating margin | -22.08% | -29.92% |
| Net margin | -21.25% | -6.93% |
| ROE | -43.94% | -8.95% |
| ROIC | -26.88% | -5.33% |
Growth (annualized)
| Metric | NVCR | SRPT |
|---|---|---|
| Revenue CAGR (5Y) | 5.12% | 26.90% |
| Total return CAGR (5Y) | -32.71% | -28.74% |
Frequently asked
- Which has grown faster, NVCR or SRPT?
- Over the past five years, SRPT grew revenue faster — NVCR at a 5.12% CAGR versus SRPT at 26.90%.
- How have NVCR and SRPT total returns compared?
- Over the past 10 years, NVCR delivered 5.67% and SRPT delivered -11.94% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Novocure ROESarepta Therapeutics ROENovocure operating marginSarepta Therapeutics operating marginNovocure revenue growthSarepta Therapeutics revenue growthNovocure free cash flowSarepta Therapeutics free cash flow
Novocure & Sarepta Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.